Table 4.
ReCORD-FL Versus SCHOLAR-5
| Endpoint | SCHOLAR-5 | ReCORD-FL | |
|---|---|---|---|
| 4L Treatment (n = 85) | 4L Treatment (n = 147) | 5L Treatment (n = 96) | |
| CR | 29.9% | 32.0% | 21.9% |
| ORR | 49.9% | 61.2% | 45.8% |
| TNT-D, median (95% CI), months | 14.4 (6.2-25.8) | 13.2 (11.3-19.0) | 10.1 (7.3-13.1) |
| PFS/EFS, median (95% CI), months | 12.7 (6.2-14.7) | 12.0 (10.7-16.0) | 9.4 (6.8-13.1) |
| OS, median (95% CI), months | 59.8 (21.9-NR) | 95.8 (51.9-134.9) | 46.3 (31.7-76.5) |
4L = fourth line; 5L = fifth line; CR = complete response; EFS = event-free survival; NR = not reached; ORR = overall response rate; OS = overall survival; PFS = progression-free survival; TNT-D = time to next treatment or death.